BR0203861A - Processo para preparação de alcanossulfonilpiridinas - Google Patents

Processo para preparação de alcanossulfonilpiridinas

Info

Publication number
BR0203861A
BR0203861A BR0203861-7A BR0203861A BR0203861A BR 0203861 A BR0203861 A BR 0203861A BR 0203861 A BR0203861 A BR 0203861A BR 0203861 A BR0203861 A BR 0203861A
Authority
BR
Brazil
Prior art keywords
alkanesulfonylpyridines
preparing
inflammation
formula
preparation
Prior art date
Application number
BR0203861-7A
Other languages
English (en)
Inventor
Jolanta Nowakowski
Dieter Christian Haag
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0203861A publication Critical patent/BR0203861A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE ALCANOSSULFONILPIRIDINAS". A invenção refere-se a um processo para preparação de alcanossulfonilpiridinas da fórmula 1: no qual R^ 1^ é como aqui definido. Os compostos da fórmula 1 são úteis na preparação de pirazóis piridil-substituídos usados no tratamento ou alívio de inflamações e outros distúrbios associados a inflamações.
BR0203861-7A 2001-09-28 2002-09-23 Processo para preparação de alcanossulfonilpiridinas BR0203861A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32564801P 2001-09-28 2001-09-28

Publications (1)

Publication Number Publication Date
BR0203861A true BR0203861A (pt) 2003-09-16

Family

ID=23268791

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0203861-7A BR0203861A (pt) 2001-09-28 2002-09-23 Processo para preparação de alcanossulfonilpiridinas

Country Status (14)

Country Link
US (1) US6590103B2 (pt)
EP (1) EP1298116A1 (pt)
JP (1) JP2003160564A (pt)
KR (1) KR20030027869A (pt)
CN (1) CN1410420A (pt)
BR (1) BR0203861A (pt)
CA (1) CA2405328A1 (pt)
HU (1) HUP0203242A2 (pt)
IL (1) IL151836A0 (pt)
MX (1) MXPA02009565A (pt)
PL (1) PL356317A1 (pt)
RU (1) RU2224747C1 (pt)
YU (1) YU67702A (pt)
ZA (1) ZA200207740B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540639C (en) 2003-10-02 2010-08-31 Pharmacia & Upjohn Company Llc Salts and polymorphs of a pyrrole-substituted indolinone compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668539A (en) * 1970-07-29 1972-06-06 Bell Telephone Labor Inc Low level amplifier
US4511857A (en) * 1982-09-17 1985-04-16 Gunderson Steven J Output following intermediate cascode circuit
FI100751B (fi) * 1996-06-11 1998-02-13 Nikolay Tchamov Pienikohinainen vahvistin
US6069534A (en) * 1997-12-04 2000-05-30 Trw Inc. Balance photo-receiver with complementary HBT common-base push pull pre-amplifier
DE60004001T2 (de) * 1999-12-03 2004-04-15 Pfizer Products Inc., Groton Acetylenderivate zur Verwendung als schmerzstillendes oder entzündungshemmendes Mittel
WO2001040216A1 (en) * 1999-12-03 2001-06-07 Pfizer Products Inc. Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents

Also Published As

Publication number Publication date
MXPA02009565A (es) 2003-03-12
YU67702A (sh) 2004-12-31
PL356317A1 (en) 2003-04-07
RU2224747C1 (ru) 2004-02-27
HUP0203242A2 (hu) 2003-08-28
EP1298116A1 (en) 2003-04-02
US20030092914A1 (en) 2003-05-15
US6590103B2 (en) 2003-07-08
KR20030027869A (ko) 2003-04-07
CN1410420A (zh) 2003-04-16
IL151836A0 (en) 2003-04-10
CA2405328A1 (en) 2003-03-28
ZA200207740B (en) 2004-03-26
JP2003160564A (ja) 2003-06-03
RU2002125831A (ru) 2004-03-27
HU0203242D0 (pt) 2002-11-28

Similar Documents

Publication Publication Date Title
BR0206435A (pt) Composto, composição farmacêutica, métodos de tratar a angiogênese em um paciente, de tratar distúrbios relacionados com kdr e proliferativos em um mamìfero, uso de um composto, e, processo para preparar compostos
BR0112093A (pt) Derivados de sulfonil-pirrolidina úteis no tratamento de distúrbios neurológicos
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
BR0204588A (pt) Derivados de n-alquil-adamantil-triazinil-benzamida
WO2003032994A3 (de) 5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
BR0208489A (pt) Derivados de n-(arilsulfonil) beta-aminoácidos, comportando um grupo aminoetilado substituìdo, o respectivo processo de preparação e as composições farmacêuticas que os contêm
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
ATE361287T1 (de) Neue indol-2-on derivate
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
BRPI0407253A (pt) Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos
BR0208891A (pt) Derivados de dihidro-benzo[b]-[1,4]diazepin-2-ona como antagonistas de mglur2 ii
BR0317717A (pt) Composto, composição farmacêutica, uso de um composto, método para tratar um humano sofrendo de uma doença, e, processo para a preparação de um composto
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9916282A (pt) Composto, uso de um um composto e método de tratamento
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
WO2002002518A3 (en) Compounds to treat alzheimer's disease
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
WO2002002520A3 (en) Compounds to treat alzheimer's disease
SE0100172D0 (sv) New inhibitors against galectins
BR0212101A (pt) 7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BRPI0417376A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008.